|
Volumn 85, Issue , 2003, Pages 31-38
|
Biomarker assays for phosphorylated MAP kinase. Their utility for measurement of MEK inhibition.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL MARKER;
ENZYME INHIBITOR;
MAP2K1 PROTEIN, HUMAN;
MAP2K1 PROTEIN, MOUSE;
MITOGEN ACTIVATED PROTEIN KINASE;
MITOGEN ACTIVATED PROTEIN KINASE KINASE;
MITOGEN ACTIVATED PROTEIN KINASE KINASE 1;
PHORBOL 13 ACETATE 12 MYRISTATE;
PHOSPHOPROTEIN;
PROTEIN SERINE THREONINE KINASE;
TUMOR PROTEIN;
ANIMAL;
DRUG ANTAGONISM;
DRUG EFFECT;
ENZYMOLOGY;
HUMAN;
LEUKEMIA CELL LINE;
LYMPHOCYTE ACTIVATION;
METABOLISM;
MOUSE;
PHOSPHORYLATION;
PROTEIN PROCESSING;
REVIEW;
SIGNAL TRANSDUCTION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL MARKERS;
ENZYME INHIBITORS;
HUMANS;
JURKAT CELLS;
LYMPHOCYTE ACTIVATION;
MAP KINASE KINASE 1;
MAP KINASE SIGNALING SYSTEM;
MICE;
MITOGEN-ACTIVATED PROTEIN KINASE KINASES;
MITOGEN-ACTIVATED PROTEIN KINASES;
NEOPLASM PROTEINS;
PHOSPHOPROTEINS;
PHOSPHORYLATION;
PROTEIN PROCESSING, POST-TRANSLATIONAL;
PROTEIN-SERINE-THREONINE KINASES;
TETRADECANOYLPHORBOL ACETATE;
MLCS;
MLOWN;
|
EID: 0037942908
PISSN: 15431894
EISSN: None
Source Type: Journal
DOI: 10.1385/1-59259-380-1:31 Document Type: Review |
Times cited : (8)
|
References (6)
|